Analytical Data
-
基因名
C6orf225
- Application
-
别名
FAM229B; C6orf225Protein FAM229B
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q4G0N7
-
表达区间
1-80aa
-
氨基酸序列
MPFQFGTQPRRFPVEGGDSSIELEPGLSSSAACNGKEMSPTRQLRRCPGSHCLTITDVPVTVYATTRKPPAQSSKEMHPK
-
分子量
35.2 KDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C6orf225, also known as the "chromosome 6 open reading frame 225," has emerged as a protein of interest in biomedical research due to its potential involvement in various pathological conditions. Recent advances in genomic and proteomic technologies have facilitated the identification of C6orf225, prompting investigations into its biological functions and implications in health and disease. Initial studies suggest that C6orf225 may play a role in cellular processes such as cell proliferation, differentiation, and apoptosis, which are critical for maintaining tissue homeostasis. Furthermore, preliminary findings indicate a possible correlation between C6orf225 expression levels and certain cancers, as well as autoimmune disorders, raising questions about its utility as a biomarker or therapeutic target. Despite these promising leads, comprehensive functional studies are still required to elucidate the precise mechanisms by which C6orf225 operates at the molecular level. The production of recombinant C6orf225 protein has therefore become a pivotal focus, enabling researchers to conduct in-depth analyses of its structure and function. By understanding the biochemical properties and interaction networks of C6orf225, scientists aim to uncover its role in disease pathology and develop innovative strategies for intervention. This research not only contributes to our fundamental understanding of protein biology but also holds the potential to advance diagnostic and therapeutic approaches in clinical settings. As investigations continue, C6orf225 stands out as a significant candidate for further exploration within the burgeoning field of molecular medicine.












